0
ARTICLE |

Final Outcome Results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS):  A Randomized Controlled Trial

Nemat O. Borhani, MD, MPH; Michele Mercuri, MD, PhD; Patricia A. Borhani; Vardaman M. Buckalew, MD; Maria Canossa-Terris, MD; Albert A. Carr, MD; Tissa Kappagoda, MD, PhD; Michael V. Rocco, MD, MS; Harold W. Schnaper, MD; James R. Sowers, MD; M. Gene Bond, PhD
JAMA. 1996;276(10):785-791. doi:10.1001/jama.1996.03540100029024.
Text Size: A A A
Published online

Objective.  —To compare the rate of progression of mean maximum intimal-medial thickness (IMT) in carotid arteries, using quantitative B-mode ultrasound imaging, during antihypertensive therapy with isradipine vs hydrochlorothiazide.

Design.  —Randomized, double-blind, positive-controlled trial.

Setting.  —Nine medical center clinics.

Population.  —A total of 883 patients with baseline mean ±SD systolic and diastolic blood pressure (SBP and DBP, respectively) of 149.7±16.6 and 96.5±5.1 mm Hg, age of 58.5±8.5 years, and maximum IMT of 1.17±0.20 mm.

Interventions.  —Twice daily doses of isradipine (2.5-5.0 mg) or hydrochlorothiazide (12.5-25 mg).

Main Outcome Measure (Primary End Point).  —Rate of progression of mean maximum IMT in 12 carotid focal points over 3 years.

Results.  —There was no difference in the rate of progression of mean maximum IMT between isradipine and hydrochlorothiazide over 3 years (P=.68). There was a higher incidence of major vascular events (eg, myocardial infarction, stroke, congestive heart failure, angina, and sudden death) in isradipine (n=25; 5.65%) vs hydrochlorothiazide (n=14; 3.17%) (P=.07), and a significant increase in nonmajor vascular events and procedures (eg, transient ischemic attack, dysrhythmia, aortic valve replacement, and femoral popliteal bypass graft) in isradipine (n=40; 9.05%) vs hydrochlorothiazide (n=23; 5.22%) (P=.02). At 6 months, mean DBP decreased by 13.0 mm Hg in both groups, and mean SBP decreased by 19.5 mm Hg in hydrochlorothiazide and 16.0 mm Hg in isradipine (P=.002); the difference in SBP between the 2 groups persisted throughout the study but did not explain the increased incidence of vascular events in patients treated with isradipine.

Conclusion.  —The rate of progression of mean maximum IMT in carotid arteries, the surrogate end point in this study, did not differ between the 2 treatment groups. The increased incidence of vascular events in patients receiving isradipine compared with hydrochlorothiazide is of concern and should be studied further.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();